Apollo Hospitals Enterprise Limited vs Shukra Pharmaceuticals Ltd

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Shukra Pharmaceuticals Ltd (SHUKRAPHARMACEUTICALSLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs SHUKRAPHARMACEUTICALSLTD on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation40
  • Profitability04
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

APOLLOHOSP takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
72.80
13.46
P/B ratio
16.66
0.22%
Dividend yield
0.03%
₹135.04
EPS
₹0.22

Profitability

SHUKRAPHARMACEUTICALSLTD takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
28.90%
17.31%
Return on capital
22.00%
14.94%
EBITDA margin
39.00%
7.94%
Net margin
30.30%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
-1.31%
33.35%
Profit CAGR (3Y)
70.51%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹1,706 Cr
₹25,229 Cr
Revenue
₹33 Cr
₹2,003 Cr
Net profit
₹10 Cr
0.90
Debt / equity
0.06
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Shukra Pharmaceuticals Ltd
  • + ["Company is almost debt free.", "Company is expected to give good quarter", "Company has delivered good profit growth of 175% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 28.2%"]
  • − ["Stock is trading at 19.0 times its book value", "Debtor days have increased from 122 to 148 days."]
Apollo Hospitals Enterprise Limited full analysis Shukra Pharmaceuticals Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.